fluorouracil has been researched along with Intestinal Obstruction in 45 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Intestinal Obstruction: Any impairment, arrest, or reversal of the normal flow of INTESTINAL CONTENTS toward the ANAL CANAL.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metastatic/advanced colorectal cancer is considered a resistant disease and oncologic emergencies secondary to advanced disease may be regarded with a nihilistic attitude." | 5.33 | Oncologic emergencies secondary to advanced colorectal cancer successfully treated with oxaliplatin/5-fluorouracil/leucovorin: report of three cases. ( Anselmi, E; Bertè, R; Bidin, L; Cavanna, L; Civardi, G; Lazzaro, A; Moroni, CF; Palladino, MA; Rodinò, C; Vallisa, D, 2005) |
| "For patients with incurable stage IV colorectal cancer, minimally symptomatic primary tumours were left in situ and 5-fluorouracil-based chemotherapy was administered systemically." | 3.71 | Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer. ( Guillou, PJ; Guthrie, JA; O'Riordain, DS; Ride, E; Sarela, AI; Seymour, MT, 2001) |
| "Patients affected with Stage IV colorectal cancer and unresectable metastases represent a heterogeneous group." | 2.90 | Resection or Stenting in the Treatment of Symptomatic Advanced Metastatic Rectal Cancer: A Dilemma. ( Crocetti, D; DE Felice, F; DE Toma, G; Fiori, E; Lamazza, A; Mingoli, A; Sapienza, P; Sterpetti, AV; Tarallo, M, 2019) |
| "Patients (N = 207) with nonresectable rectal cancer were randomized to preoperative CRT or RT (2 Gy × 25 ± 5-fluorouracil/leucovorin)." | 2.76 | Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study. ( Berglund, Å; Bruheim, K; Brændengen, M; Cvancarova, M; Glimelius, B; Tveit, KM, 2011) |
| "Clinical studies were prospectively conducted to quantitate the toxic side-effects of 5-FU administered by either the intravenous (i." | 2.66 | Toxicity studies of adjuvant intravenous versus intraperitoneal 5-FU in patients with advanced primary colon or rectal cancer. ( Barofsky, I; Gianola, FJ; Meyers, CE; Sugarbaker, PH; White, DE, 1986) |
| "Risk factors for colorectal cancer are mainly dietary and genetic." | 2.46 | Colorectal cancer treatment. ( Landau, D; Qureshi, A; Ross, P; Verma, A, 2010) |
| "SEMS followed by neoadjuvant chemotherapy prior to elective surgery appears to be safe and well tolerated in patients with obstructing left-sided colon cancer." | 1.56 | Efficacy and safety of self-expanding metallic stent placement followed by neoadjuvant chemotherapy and scheduled surgery for treatment of obstructing left-sided colonic cancer. ( Han, JG; Wang, YB; Wang, ZJ; Wei, GH; Yi, BQ; Zeng, WG; Zhai, ZW; Zhao, BC, 2020) |
| "A diagnosis of local recurrence of rectal cancer, peritoneal metastasis and metastatic liver cancer was confirmed." | 1.48 | [A Case Describing Treatment with FOLFIRI plus Bevacizumab after a Self-Expandable Metallic Stent Placement for Local Recurrence]. ( Kodama, M; Kondo, S; Miyahara, Y; Yamazaki, K; Yokoyama, M; Yoshida, A, 2018) |
| "436 patients with unresectable pancreatic cancers received HIFU treatment; the other 253 patients received non-HIFU treatment." | 1.43 | A retrospective analysis of survival factors of high intensity focused ultrasound (HIFU) treatment for unresectable pancreatic cancer. ( Chen, QW; Cheng, CS; Meng, ZQ; Ning, ZY; Shi, WD; Song, LB; Wang, K; Wang, P; Xie, J; Xu, LT; Zhang, CY; Zhu, XY; Zhuang, LP, 2016) |
| "Radiotherapy for advanced rectal cancer is an important treatment to reduce local recurrence." | 1.40 | Late complications after proctectomy in rectal cancer patients who underwent radiotherapy. ( Jung, SH; Kim, JH; Kim, SH, 2014) |
| "The most common malignancy is squamous cell carcinoma, which consists of about 75% of malignant transformations." | 1.35 | Squamous cell carcinoma arising in an ovarian mature cystic teratoma: a case report. ( Azadbakht, F; Emami-Aleagha, M; Hajarizadeh, B; Keshvari, A; Rosai, J; Sedighi, S; Shariat-Torbaghan, S, 2009) |
| "Prognosis of stage II colorectal cancer varies." | 1.35 | [Prognostic analysis of 443 cases of stage II colorectal cancer and the value of adjuvant chemotherapy]. ( Ding, PR; Li, LR; Lin, JZ; Pan, ZZ; Peng, ZH; Wan, DS; Wu, XJ; Zhou, ZG, 2009) |
| "Metastatic/advanced colorectal cancer is considered a resistant disease and oncologic emergencies secondary to advanced disease may be regarded with a nihilistic attitude." | 1.33 | Oncologic emergencies secondary to advanced colorectal cancer successfully treated with oxaliplatin/5-fluorouracil/leucovorin: report of three cases. ( Anselmi, E; Bertè, R; Bidin, L; Cavanna, L; Civardi, G; Lazzaro, A; Moroni, CF; Palladino, MA; Rodinò, C; Vallisa, D, 2005) |
| "Rare reports of intestinal obstruction have been confined to the stiff plastic and stainless-steel stents." | 1.32 | A rare life-threatening complication of migrated nitinol self-expanding metallic stent (Ultraflex). ( Ho, HS; Ong, HS, 2004) |
| "Pseudomyxoma peritonei is an unusual malignancy arising from the goblet cells of the large bowel or appendix." | 1.27 | Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment. ( Kern, K; Lack, E; Sugarbaker, PH, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (20.00) | 18.7374 |
| 1990's | 3 (6.67) | 18.2507 |
| 2000's | 10 (22.22) | 29.6817 |
| 2010's | 20 (44.44) | 24.3611 |
| 2020's | 3 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, SH | 1 |
| Mbarak, HS | 1 |
| Li, YH | 1 |
| Ma, C | 1 |
| Shang, QL | 1 |
| Chen, Z | 1 |
| Bian, DJ | 1 |
| Xiao, EH | 1 |
| Fiori, E | 1 |
| Crocetti, D | 1 |
| Lamazza, A | 1 |
| DE Felice, F | 1 |
| Tarallo, M | 1 |
| Sterpetti, AV | 1 |
| Mingoli, A | 1 |
| Sapienza, P | 1 |
| DE Toma, G | 1 |
| Han, JG | 1 |
| Wang, ZJ | 1 |
| Zeng, WG | 1 |
| Wang, YB | 1 |
| Wei, GH | 1 |
| Zhai, ZW | 1 |
| Zhao, BC | 1 |
| Yi, BQ | 1 |
| Tanabe, T | 1 |
| Shida, D | 1 |
| Boku, N | 1 |
| Yoshida, T | 1 |
| Tsukamoto, S | 1 |
| Takashima, A | 1 |
| Kanemitsu, Y | 1 |
| Yokoyama, M | 1 |
| Yamazaki, K | 1 |
| Kodama, M | 1 |
| Kondo, S | 1 |
| Yoshida, A | 1 |
| Miyahara, Y | 1 |
| Yukami, H | 1 |
| Terazawa, T | 1 |
| Goto, M | 1 |
| Aoki, M | 1 |
| Asaishi, K | 1 |
| Yamaguchi, T | 1 |
| Kuwakado, S | 1 |
| Kii, T | 1 |
| Higuchi, K | 1 |
| Koda, T | 1 |
| Koike, J | 1 |
| Funahashi, K | 1 |
| Ushigome, M | 1 |
| Shiokawa, H | 1 |
| Kurihara, A | 1 |
| Nagashima, Y | 1 |
| Shimada, H | 1 |
| Kaneko, H | 1 |
| Babacan, T | 1 |
| Turkbeyler, IH | 1 |
| Dag, MS | 1 |
| Dilli, I | 1 |
| Balakan, O | 1 |
| Altundag, K | 1 |
| Miyamoto, Y | 1 |
| Watanabe, M | 1 |
| Sakamoto, Y | 1 |
| Shigaki, H | 1 |
| Murata, A | 1 |
| Sugihara, H | 1 |
| Etoh, K | 1 |
| Ishimoto, T | 1 |
| Iwatsuki, M | 1 |
| Baba, Y | 1 |
| Iwagami, S | 1 |
| Yoshida, N | 1 |
| Baba, H | 1 |
| van den Berg, MW | 1 |
| Sloothaak, DA | 1 |
| Dijkgraaf, MG | 1 |
| van der Zaag, ES | 1 |
| Bemelman, WA | 1 |
| Tanis, PJ | 1 |
| Bosker, RJ | 1 |
| Fockens, P | 1 |
| ter Borg, F | 1 |
| van Hooft, JE | 1 |
| Kim, SH | 1 |
| Kim, JH | 2 |
| Jung, SH | 1 |
| Muto, O | 1 |
| Sawada, T | 1 |
| Kotanagi, K | 1 |
| Sato, K | 1 |
| Kichiraku, T | 1 |
| Iwasaki, W | 1 |
| Kikkawa, M | 1 |
| Ouchi, S | 1 |
| Kotanagi, H | 1 |
| Ning, ZY | 1 |
| Cheng, CS | 1 |
| Xie, J | 1 |
| Chen, QW | 1 |
| Xu, LT | 1 |
| Zhuang, LP | 1 |
| Zhang, CY | 1 |
| Song, LB | 1 |
| Shi, WD | 1 |
| Zhu, XY | 1 |
| Wang, P | 1 |
| Wang, K | 1 |
| Meng, ZQ | 1 |
| Mitry, E | 1 |
| Shariat-Torbaghan, S | 1 |
| Emami-Aleagha, M | 1 |
| Sedighi, S | 1 |
| Azadbakht, F | 1 |
| Keshvari, A | 1 |
| Hajarizadeh, B | 1 |
| Rosai, J | 1 |
| Zhou, ZG | 1 |
| Pan, ZZ | 1 |
| Wan, DS | 1 |
| Li, LR | 1 |
| Wu, XJ | 1 |
| Ding, PR | 1 |
| Lin, JZ | 1 |
| Peng, ZH | 1 |
| Kim, CW | 1 |
| Yu, CS | 1 |
| Shin, US | 1 |
| Park, JS | 1 |
| Jung, KY | 1 |
| Kim, TW | 1 |
| Yoon, SN | 1 |
| Lim, SB | 1 |
| Kim, JC | 1 |
| Kim, HK | 1 |
| Ko, BM | 1 |
| Park, JK | 1 |
| Hong, SJ | 1 |
| Moon, JH | 1 |
| Lee, JS | 1 |
| Lee, MS | 1 |
| Kim, BS | 1 |
| Frago, R | 1 |
| Kreisler, E | 1 |
| Biondo, S | 1 |
| Salazar, R | 1 |
| Dominguez, J | 1 |
| Escalante, E | 1 |
| Brændengen, M | 1 |
| Tveit, KM | 1 |
| Bruheim, K | 1 |
| Cvancarova, M | 1 |
| Berglund, Å | 1 |
| Glimelius, B | 1 |
| Fuccio, L | 1 |
| Cennamo, V | 1 |
| Qureshi, A | 1 |
| Verma, A | 1 |
| Ross, P | 1 |
| Landau, D | 1 |
| Chen, FM | 1 |
| Yin, TC | 1 |
| Fan, WC | 1 |
| Huang, CJ | 1 |
| Hsieh, JS | 1 |
| McCahill, LE | 1 |
| Yothers, G | 1 |
| Sharif, S | 1 |
| Petrelli, NJ | 1 |
| Lai, LL | 1 |
| Bechar, N | 1 |
| Giguere, JK | 1 |
| Dakhil, SR | 1 |
| Fehrenbacher, L | 1 |
| Lopa, SH | 1 |
| Wagman, LD | 1 |
| O'Connell, MJ | 1 |
| Wolmark, N | 1 |
| Chattopadhyay, S | 1 |
| Mondal, SK | 1 |
| Saha, A | 1 |
| Manna, A | 1 |
| Kundu, SK | 1 |
| Cha, BH | 1 |
| Lee, SH | 1 |
| Kim, JE | 1 |
| Yoo, JY | 1 |
| Park, YS | 1 |
| Kim, JW | 1 |
| Jeong, SH | 1 |
| Kim, N | 1 |
| Lee, DH | 1 |
| Hwang, JH | 1 |
| Aihara, H | 1 |
| Maruoka, H | 1 |
| Kiyozaki, H | 1 |
| Konishi, F | 1 |
| Burmeister, BH | 1 |
| Schache, D | 1 |
| Burmeister, EA | 1 |
| Bell, A | 1 |
| Poulsen, MG | 1 |
| Walpole, ET | 1 |
| Mackintosh, J | 1 |
| Ho, HS | 1 |
| Ong, HS | 1 |
| Cavanna, L | 1 |
| Bertè, R | 1 |
| Bidin, L | 1 |
| Civardi, G | 1 |
| Anselmi, E | 1 |
| Lazzaro, A | 1 |
| Moroni, CF | 1 |
| Palladino, MA | 1 |
| Rodinò, C | 1 |
| Vallisa, D | 1 |
| Innis, M | 1 |
| Sandiford, N | 1 |
| Shenoy, RK | 1 |
| Prussia, PR | 1 |
| Zbar, A | 1 |
| Bruckner, HW | 1 |
| Cohen, J | 1 |
| Denck, H | 1 |
| Fuhrman, GM | 1 |
| Ota, DM | 1 |
| Danikas, D | 1 |
| Theodorou, SJ | 1 |
| Arvanitis, ML | 1 |
| Zinterhofer, LM | 1 |
| Rienzo, AA | 1 |
| Crane, CH | 1 |
| Janjan, NA | 1 |
| Abbruzzese, JL | 1 |
| Curley, S | 1 |
| Vauthey, J | 1 |
| Sawaf, HB | 1 |
| Dubrow, R | 1 |
| Allen, P | 1 |
| Ellis, LM | 1 |
| Hoff, P | 1 |
| Wolff, RA | 1 |
| Lenzi, R | 1 |
| Brown, TD | 1 |
| Lynch, P | 1 |
| Cleary, K | 1 |
| Rich, TA | 1 |
| Skibber, J | 1 |
| Sarela, AI | 1 |
| Guthrie, JA | 1 |
| Seymour, MT | 1 |
| Ride, E | 1 |
| Guillou, PJ | 1 |
| O'Riordain, DS | 1 |
| Horton, J | 1 |
| Brickner, TJ | 1 |
| Illig, WP | 1 |
| Self, J | 1 |
| Thompson, CT | 1 |
| Ueshima, Y | 1 |
| Taniguchi, H | 1 |
| Takeuchi, K | 1 |
| Oguro, A | 1 |
| Tsukuda, N | 1 |
| Shioaki, Y | 1 |
| Takahashi, T | 1 |
| Harada, M | 1 |
| Sugarbaker, PH | 2 |
| Kern, K | 1 |
| Lack, E | 1 |
| Gianola, FJ | 1 |
| Barofsky, I | 1 |
| White, DE | 1 |
| Meyers, CE | 1 |
| Rominger, CJ | 1 |
| Gunderson, LL | 1 |
| Gelber, RD | 1 |
| Conner, N | 1 |
| Clark, DG | 1 |
| Hilaris, BS | 1 |
| Ochoa, M | 1 |
| Freel, JH | 1 |
| Lokich, JJ | 1 |
| Brooks, JR | 1 |
| Donaldson, GA | 1 |
| Welch, JP | 1 |
3 reviews available for fluorouracil and Intestinal Obstruction
| Article | Year |
|---|---|
Colorectal cancer treatment.
Topics: Chemotherapy, Adjuvant; Colonic Neoplasms; Colorectal Neoplasms; Fluorouracil; Humans; Intestinal Ob | 2010 |
Progress in treatment of cancer of the large bowel.
Topics: Antineoplastic Agents; Colonic Neoplasms; Fluorouracil; Follow-Up Studies; Humans; Intestinal Obstru | 1976 |
Management of cancer of the colon.
Topics: Colitis, Ulcerative; Colon; Colonic Diseases; Colonic Neoplasms; Diagnostic Errors; Fluorouracil; Hu | 1974 |
6 trials available for fluorouracil and Intestinal Obstruction
| Article | Year |
|---|---|
Resection or Stenting in the Treatment of Symptomatic Advanced Metastatic Rectal Cancer: A Dilemma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camp | 2019 |
Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemoradiotherapy; Diagnostic | 2011 |
Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colo | 2012 |
Synchronous postoperative adjuvant chemoradiation therapy for locally advanced carcinoma of the rectum.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma; Chemotherapy, Adjuvant; | 2004 |
Toxicity studies of adjuvant intravenous versus intraperitoneal 5-FU in patients with advanced primary colon or rectal cancer.
Topics: Colonic Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Fluorouracil; Humans | 1986 |
Radiation therapy alone or in combination with chemotherapy in the treatment of residual or inoperable carcinoma of the rectum and rectosigmoid or pelvic recurrence following colorectal surgery. Radiation Therapy Oncology Group study (76-16).
Topics: Abscess; Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical T | 1985 |
36 other studies available for fluorouracil and Intestinal Obstruction
| Article | Year |
|---|---|
Neoadjuvant intra-arterial versus intravenous chemotherapy in colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluoroura | 2021 |
Efficacy and safety of self-expanding metallic stent placement followed by neoadjuvant chemotherapy and scheduled surgery for treatment of obstructing left-sided colonic cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Drug T | 2020 |
Primary Tumor-Related Complications Among Patients With Unresectable Stage IV Colorectal Cancer in the Era of Targeted Therapy: A Competing Risk Regression Analysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cetuximab; Colorectal Neoplasms; | 2021 |
[A Case Describing Treatment with FOLFIRI plus Bevacizumab after a Self-Expandable Metallic Stent Placement for Local Recurrence].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Fluorouracil; Humans; Int | 2018 |
Impact of modified FOLFOX-6 for patients with gastric cancer and a gastrointestinal obstruction.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Gastrointestinal | 2019 |
[A case of preoperative "bridge to chemotherapy" expandable metallic stent insertion and neoadjuvant therapy for obstructive colorectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Fluorouracil; Human | 2013 |
Cetuximab-induced esophageal ulcer: the first report in literature.
Topics: Abdomen, Acute; Adenocarcinoma; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemother | 2014 |
Evaluation of the necessity of primary tumor resection for synchronous metastatic colorectal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Digestive | 2014 |
Bridge-to-surgery stent placement versus emergency surgery for acute malignant colonic obstruction.
Topics: Aged; Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Colonic Diseases; Color | 2014 |
Late complications after proctectomy in rectal cancer patients who underwent radiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anastomosis, Surgical; Antineoplastic Agents; Case-C | 2014 |
Modified administration schedule of docetaxel, cisplatin, and fluorouracil for advanced or recurrent gastric cancer with gastrointestinal stenosis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Ga | 2014 |
A retrospective analysis of survival factors of high intensity focused ultrasound (HIFU) treatment for unresectable pancreatic cancer.
Topics: Adult; Aged; Aged, 80 and over; Amylases; Antimetabolites, Antineoplastic; Deoxycytidine; Feasibilit | 2016 |
A dilemma in geriatric oncology: malignant bowel obstruction in an 81-year-old man.
Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Col | 2008 |
Squamous cell carcinoma arising in an ovarian mature cystic teratoma: a case report.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Che | 2009 |
[Prognostic analysis of 443 cases of stage II colorectal cancer and the value of adjuvant chemotherapy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecita | 2009 |
Complications after sphincter-saving resection in rectal cancer patients according to whether chemoradiotherapy is performed before or after surgery.
Topics: Adenocarcinoma; Adult; Aged; Anal Canal; Anastomosis, Surgical; Antineoplastic Combined Chemotherapy | 2010 |
[A case of locally invasive obstructive jejunal cancer with curative resection after stenting and chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Endoscopy | 2010 |
Outcomes in the management of obstructive unresectable stage IV colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colore | 2010 |
Bevacizumab-based therapy and complication risk after colonic stent placement: is it time for a warning?
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic C | 2010 |
Laparoscopic management for acute malignant colonic obstruction.
Topics: Acute Disease; Adult; Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colectomy; Colo | 2012 |
Primary carcinoma of jejunum--a case report.
Topics: Adenocarcinoma; Aged; Anastomosis, Surgical; Antimetabolites, Antineoplastic; Capecitabine; Chemothe | 2012 |
Endoscopic self-expandable metallic stent placement in malignant pyloric or duodenal obstruction: does chemotherapy affect stent patency?
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cholangiopancreatography, Endoscopic Retrograd | 2013 |
Sclerosing encapsulating peritonitis (SEP) as a delayed complication of continuous hyperthermic peritoneal perfusion (CHPP): report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; | 2003 |
A rare life-threatening complication of migrated nitinol self-expanding metallic stent (Ultraflex).
Topics: Adenocarcinoma; Aged; Alloys; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Ther | 2004 |
Oncologic emergencies secondary to advanced colorectal cancer successfully treated with oxaliplatin/5-fluorouracil/leucovorin: report of three cases.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; | 2005 |
Carcinoma of the jejunum with multideposit peritoneal seeding, resection and intraperitoneal chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Infusions, Par | 2005 |
MTX/5-FU trials in gastrointestinal and other cancers.
Topics: Aged; Anemia; Conjunctivitis; Drug Evaluation; Drug Therapy, Combination; Fluorouracil; Gastrointest | 1983 |
[Regional cytostatic infusion therapy in patients with inoperable gastrointestinal carcinomas and metastases in the liver (author's transl)].
Topics: Adult; Aged; Chemotherapy, Cancer, Regional Perfusion; Colostomy; Fluorouracil; Gastrointestinal Neo | 1980 |
Laparoscopic intestinal stomas.
Topics: Adenocarcinoma; Adult; Aged; Anus Neoplasms; Carcinoma, Squamous Cell; Colonic Diseases; Colostomy; | 1994 |
Malar metastasis from rectal carcinoma: a case report.
Topics: Adenocarcinoma; Antidotes; Antimetabolites, Antineoplastic; Colonic Neoplasms; Fatal Outcome; Female | 1999 |
Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antimetabolites, Antineoplastic; Cohort Studie | 2001 |
Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer.
Topics: Abdominal Pain; Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neop | 2001 |
[Superior mesenteric arterial infusion chemotherapy against intestinal obstruction caused by peritoneal carcinomatosis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Humans | 1991 |
Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment.
Topics: Adenocarcinoma, Mucinous; Adult; Colonic Neoplasms; Combined Modality Therapy; Drug Therapy, Combina | 1987 |
Interdisciplinary approach to advanced ovarian cancer.
Topics: Alkylating Agents; Ascites; Chlorambucil; Dactinomycin; Drug Therapy, Combination; Female; Fluoroura | 1974 |
Disappearance of disseminated pancreatic carcinoma with combined chemotherapy.
Topics: Adult; Carcinoma, Intraductal, Noninfiltrating; Carmustine; Duodenum; Fluorouracil; Gastrectomy; Hum | 1973 |